MyMed Rx Plus Corporation President Jojo Soliman shows a box of Favipiravir, commercially known as Avigan, to members of the media on Wednesday. T
he antiviral drug will be used only in patients being treated at the Chinese General Hospital as approved by Food and Drug Administration of the Philippines through a compassionate special permit issued on September 7, 2020.
The Department of Health said that the clinical trials for Avigan, which will be tested on 100 patients, may begin this September.